{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T18:17:14Z","timestamp":1793643434767,"version":"4.5.1"},"reference-count":191,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"Innovative Research Group Project of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172230"],"award-info":[{"award-number":["82172230"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jilin Province Science and Technology Development Plan Project","award":["20190902007TC"],"award-info":[{"award-number":["20190902007TC"]}]},{"name":"the Life Spring AKY Pharmmaceuticals Corporation","award":["20210472."],"award-info":[{"award-number":["20210472."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-025-04431-1","type":"journal-article","created":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T07:34:05Z","timestamp":1750145645000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["The role and mechanism of mesenchymal stem cells in immunomodulation of type 1 diabetes mellitus and its complications: recent research progress and challenges: a review"],"prefix":"10.1186","volume":"16","author":[{"given":"Chengran","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5116-875X","authenticated-orcid":false,"given":"Jinlan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"4431_CR1","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1503\/cmaj.060244","volume":"175","author":"KM Gillespie","year":"2006","unstructured":"Gillespie KM. Type 1 diabetes: pathogenesis and prevention. CMAJ Can Med Assoc J. 2006;175:165\u201370.","journal-title":"CMAJ Can Med Assoc J"},{"key":"4431_CR2","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.ecl.2010.05.011","volume":"39","author":"DM Maahs","year":"2010","unstructured":"Maahs DM, West NA, Lawrence JM, Mayer-Davis EJ. Epidemiology of type 1 diabetes. Endocrinol Metab Clin. 2010;39:481\u201397.","journal-title":"Endocrinol Metab Clin"},{"key":"4431_CR3","doi-asserted-by":"publisher","first-page":"e3749","DOI":"10.1002\/dmrr.3749","volume":"40","author":"I Hormaz\u00e1bal-Aguayo","year":"2024","unstructured":"Hormaz\u00e1bal-Aguayo I, Ezzatvar Y, Huerta-Uribe N, Ram\u00edrez-V\u00e9lez R, Izquierdo M, Garc\u00eda-Hermoso A. Incidence of type 1 diabetes mellitus in children and adolescents under 20 years of age across 55 countries from 2000 to 2022: a systematic review with meta-analysis. Diabetes Metab Res Rev. 2024;40:e3749.","journal-title":"Diabetes Metab Res Rev"},{"key":"4431_CR4","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nrendo.2011.106","volume":"7","author":"E Lalla","year":"2011","unstructured":"Lalla E, Papapanou PN. Diabetes mellitus and periodontitis: a tale of two common interrelated diseases. Nat Rev Endocrinol. 2011;7:738\u201348.","journal-title":"Nat Rev Endocrinol"},{"key":"4431_CR5","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.stem.2023.04.002","volume":"30","author":"NJ Hogrebe","year":"2023","unstructured":"Hogrebe NJ, Ishahak M, Millman JR. Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes. Cell Stem Cell. 2023;30:530\u201348.","journal-title":"Cell Stem Cell"},{"key":"4431_CR6","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.3390\/ijms18091852","volume":"18","author":"FJ Vizoso","year":"2017","unstructured":"Vizoso FJ, Eiro N, Cid S, Schneider J, Perez-Fernandez R. Mesenchymal stem cell secretome: toward cell-free therapeutic strategies in regenerative medicine. Int J Mol Sci. 2017;18:1852.","journal-title":"Int J Mol Sci"},{"key":"4431_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nbt.2816","volume":"32","author":"JA Ankrum","year":"2014","unstructured":"Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol. 2014;32:252\u201360.","journal-title":"Nat Biotechnol"},{"key":"4431_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","volume":"8","author":"M Dominici","year":"2006","unstructured":"Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini FC, Krause DS, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315\u20137.","journal-title":"Cytotherapy"},{"key":"4431_CR9","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41536-024-00382-y","volume":"10","author":"M Hodgson-Garms","year":"2025","unstructured":"Hodgson-Garms M, Moore MJ, Martino MM, Kelly K, Frith JE. Proteomic profiling of iPSC and tissue-derived MSC secretomes reveal a global signature of inflammatory licensing. NPJ Regen Med. 2025;10:7.","journal-title":"NPJ Regen Med"},{"key":"4431_CR10","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.stemcr.2022.11.006","volume":"18","author":"A Ganguly","year":"2022","unstructured":"Ganguly A, Swaminathan G, Garcia-Marques F, Regmi S, Yarani R, Primavera R, et al. Integrated transcriptome-proteome analyses of human stem cells reveal source-dependent differences in their regenerative signature. Stem Cell Rep. 2022;18:190\u2013204.","journal-title":"Stem Cell Rep"},{"key":"4431_CR11","doi-asserted-by":"publisher","first-page":"11906","DOI":"10.3390\/ijms252211906","volume":"25","author":"S Munti\u00f3n","year":"2024","unstructured":"Munti\u00f3n S, S\u00e1nchez-Luis E, D\u00edez-Campelo M, Blanco JF, S\u00e1nchez-Guijo F, De Las RJ. Novel gene biomarkers specific to human mesenchymal stem cells isolated from bone marrow. Int J Mol Sci. 2024;25:11906.","journal-title":"Int J Mol Sci"},{"key":"4431_CR12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13287-023-03381-w","volume":"14","author":"M Peshkova","year":"2023","unstructured":"Peshkova M, Korneev A, Suleimanov S, Vlasova II, Svistunov A, Kosheleva N, et al. MSCs\u2019 conditioned media cytokine and growth factor profiles and their impact on macrophage polarization. Stem Cell Res Ther. 2023;14:142.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR13","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s13287-023-03352-1","volume":"14","author":"S Calcat-I-Cervera","year":"2023","unstructured":"Calcat-I-Cervera S, Rendra E, Scaccia E, Amadeo F, Hanson V, Wilm B, et al. Harmonised culture procedures minimise but do not eliminate mesenchymal stromal cell donor and tissue variability in a decentralised multicentre manufacturing approach. Stem Cell Res Ther. 2023;14:120.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR14","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1007\/s00125-020-05211-7","volume":"63","author":"MJ Redondo","year":"2020","unstructured":"Redondo MJ, Hagopian WA, Oram R, Steck AK, Vehik K, Weedon M, et al. The clinical consequences of heterogeneity within and between different diabetes types. Diabetologia. 2020;63:2040\u20138.","journal-title":"Diabetologia"},{"key":"4431_CR15","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.2337\/dc20-0604","volume":"43","author":"A Parviainen","year":"2020","unstructured":"Parviainen A, But A, Siljander H, Knip M, Finnish Pediatric Diabetes Register. Decreased incidence of type 1 diabetes in young Finnish children. Diabetes Care. 2020;43:2953\u20132358.","journal-title":"Diabetes Care"},{"key":"4431_CR16","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/nature08933","volume":"464","author":"JA Bluestone","year":"2010","unstructured":"Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature. 2010;464:1293\u2013300.","journal-title":"Nature"},{"key":"4431_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0140-6736(01)05415-0","volume":"358","author":"MA Atkinson","year":"2001","unstructured":"Atkinson MA, Eisenbarth GS. Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet. 2001;358:221\u20139.","journal-title":"Lancet"},{"key":"4431_CR18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/88694","volume":"2","author":"KH Lee","year":"2001","unstructured":"Lee KH, Wucherpfennig KW, Wiley DC. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat Immunol. 2001;2:501\u20137.","journal-title":"Nat Immunol"},{"key":"4431_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00125-012-2745-4","volume":"56","author":"SJ Richardson","year":"2013","unstructured":"Richardson SJ, Leete P, Bone AJ, Foulis AK, Morgan NG. Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1. Diabetologia. 2013;56:185\u201393.","journal-title":"Diabetologia"},{"key":"4431_CR20","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1093\/aje\/kwp065","volume":"169","author":"T Harder","year":"2009","unstructured":"Harder T, Roepke K, Diller N, Stechling Y, Dudenhausen JW, Plagemann A. Birth weight, early weight gain, and subsequent risk of type 1 diabetes: systematic review and meta-analysis. Am J Epidemiol. 2009;169:1428\u201336.","journal-title":"Am J Epidemiol"},{"key":"4431_CR21","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1007\/s00018-017-2473-5","volume":"74","author":"N Li","year":"2017","unstructured":"Li N, Hua J. Interactions between mesenchymal stem cells and the immune system. Cell Mol Life Sci CMLS. 2017;74:2345\u201360.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"4431_CR22","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1182\/blood-2010-02-270777","volume":"116","author":"F Gieseke","year":"2010","unstructured":"Gieseke F, B\u00f6hringer J, Bussolari R, Dominici M, Handgretinger R, M\u00fcller I. Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells. Blood. 2010;116:3770\u20139.","journal-title":"Blood"},{"key":"4431_CR23","doi-asserted-by":"publisher","first-page":"37894","DOI":"10.1038\/srep37894","volume":"6","author":"L Li","year":"2016","unstructured":"Li L, Hui H, Jia X, Zhang J, Liu Y, Xu Q, et al. Infusion with human bone marrow-derived mesenchymal stem cells improves \u03b2-cell function in patients and non-obese mice with severe diabetes. Sci Rep. 2016;6:37894.","journal-title":"Sci Rep"},{"key":"4431_CR24","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1111\/j.1365-2249.2010.04178.x","volume":"161","author":"FR Li","year":"2010","unstructured":"Li FR, Wang XG, Deng CY, Qi H, Ren LL, Zhou HX. Immune modulation of co-transplantation mesenchymal stem cells with islet on T and dendritic cells. Clin Exp Immunol. 2010;161:357\u201363.","journal-title":"Clin Exp Immunol"},{"key":"4431_CR25","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13287-022-02855-7","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Le X, Zheng S, Zhang K, He J, Liu M, et al. MicroRNA-146a-5p-modified human umbilical cord mesenchymal stem cells enhance protection against diabetic nephropathy in rats through facilitating M2 macrophage polarization. Stem Cell Res Ther. 2022;13:171.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR26","doi-asserted-by":"publisher","first-page":"9433","DOI":"10.1002\/jcb.27260","volume":"119","author":"S Nojehdehi","year":"2018","unstructured":"Nojehdehi S, Soudi S, Hesampour A, Rasouli S, Soleimani M, Hashemi SM. Immunomodulatory effects of mesenchymal stem cell-derived exosomes on experimental type-1 autoimmune diabetes. J Cell Biochem. 2018;119:9433\u201343.","journal-title":"J Cell Biochem"},{"key":"4431_CR27","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.stemcr.2017.04.008","volume":"8","author":"T Shigemoto-Kuroda","year":"2017","unstructured":"Shigemoto-Kuroda T, Oh JY, Kim D-K, Jeong HJ, Park SY, Lee HJ, et al. MSC-derived extracellular vesicles attenuate immune responses in two autoimmune murine models: type 1 diabetes and uveoretinitis. Stem Cell Rep. 2017;8:1214\u201325.","journal-title":"Stem Cell Rep"},{"key":"4431_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13287-020-01756-x","volume":"11","author":"W Liu","year":"2020","unstructured":"Liu W, Yu M, Xie D, Wang L, Ye C, Zhu Q, et al. Melatonin-stimulated MSC-derived exosomes improve diabetic wound healing through regulating macrophage M1 and M2 polarization by targeting the PTEN\/AKT pathway. Stem Cell Res Ther. 2020;11:259.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR29","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.immuni.2007.11.021","volume":"28","author":"C-WJ Lio","year":"2008","unstructured":"Lio C-WJ, Hsieh C-S. A two-step process for thymic regulatory T cell development. Immunity. 2008;28:100\u201311.","journal-title":"Immunity"},{"key":"4431_CR30","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1007\/s00125-017-4377-1","volume":"60","author":"CM Hull","year":"2017","unstructured":"Hull CM, Peakman M, Tree TIM. Regulatory T cell dysfunction in type 1 diabetes: what\u2019s broken and how can we fix it? Diabetologia. 2017;60:1839\u201350.","journal-title":"Diabetologia"},{"key":"4431_CR31","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s00109-023-02371-y","volume":"101","author":"X Zhong","year":"2023","unstructured":"Zhong X, Chen J, Wen B, Wu X, Li M, Du F, et al. Potential role of mesenchymal stem cells in T cell aging. J Mol Med. 2023;101:1365\u201378.","journal-title":"J Mol Med"},{"key":"4431_CR32","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2020.06.009","volume":"41","author":"N Song","year":"2020","unstructured":"Song N, Scholtemeijer M, Shah K. Mesenchymal stem cell immunomodulation: mechanisms and therapeutic potential. Trends Pharmacol Sci. 2020;41:653\u201364.","journal-title":"Trends Pharmacol Sci"},{"key":"4431_CR33","doi-asserted-by":"publisher","first-page":"3087","DOI":"10.1002\/stem.2104","volume":"33","author":"C Consentius","year":"2015","unstructured":"Consentius C, Aky\u00fcz L, Schmidt-Lucke JA, Tsch\u00f6pe C, Pinzur L, Ofir R, et al. Mesenchymal stromal cells prevent allostimulation in vivo and control checkpoints of Th1 priming: migration of human DC to lymph nodes and NK cell activation. Stem Cells. 2015;33:3087\u201399.","journal-title":"Stem Cells"},{"key":"4431_CR34","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s13577-023-00868-9","volume":"36","author":"C Wu","year":"2023","unstructured":"Wu C, Liu W, Liu Y, Xu T, Li M, Li X, et al. Human umbilical cord mesenchymal stem cell-derived TGFBI attenuates streptozotocin-induced type 1 diabetes mellitus by inhibiting T-cell proliferation. Hum Cell. 2023;36:997\u20131010.","journal-title":"Hum Cell"},{"key":"4431_CR35","doi-asserted-by":"publisher","first-page":"108563","DOI":"10.1016\/j.pharmthera.2023.108563","volume":"253","author":"P Yadav","year":"2024","unstructured":"Yadav P, Singh SK, Rajput S, Allawadhi P, Khurana A, Weiskirchen R, et al. Therapeutic potential of stem cells in regeneration of liver in chronic liver diseases: current perspectives and future challenges. Pharmacol Ther. 2024;253:108563.","journal-title":"Pharmacol Ther"},{"key":"4431_CR36","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1002\/ijc.30265","volume":"139","author":"T Ghosh","year":"2016","unstructured":"Ghosh T, Barik S, Bhuniya A, Dhar J, Dasgupta S, Ghosh S, et al. Tumor-associated mesenchymal stem cells inhibit na\u00efve T cell expansion by blocking cysteine export from dendritic cells. Int J Cancer. 2016;139:2068\u201381.","journal-title":"Int J Cancer"},{"key":"4431_CR37","doi-asserted-by":"publisher","first-page":"13689","DOI":"10.3390\/ijms241813689","volume":"24","author":"A Fracchia","year":"2023","unstructured":"Fracchia A, Khare D, Da\u2019na S, Or R, Buxboim A, Nachmias B, et al. Mesenchymal stromal cell-derived small extracellular vesicles modulate apoptosis, TNF alpha and interferon gamma response gene mRNA expression in T lymphocytes. Int J Mol Sci. 2023;24:13689.","journal-title":"Int J Mol Sci"},{"key":"4431_CR38","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s13287-024-03834-w","volume":"15","author":"C Li","year":"2024","unstructured":"Li C, Wu F, Mao J, Wang Y, Zhu J, Hong K, et al. Mesenchymal stem cells-derived extracellular vesicles ameliorate lupus nephritis by regulating T and B cell responses. Stem Cell Res Ther. 2024;15:216.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR39","doi-asserted-by":"publisher","first-page":"e23226","DOI":"10.1096\/fj.202300674RR","volume":"37","author":"Y Xia","year":"2023","unstructured":"Xia Y, Cheng T, Zhang C, Zhou M, Hu Z, Kang F, et al. Human bone marrow mesenchymal stem cell-derived extracellular vesicles restore Th17\/Treg homeostasis in periodontitis via miR-1246. FASEB J. 2023;37:e23226.","journal-title":"FASEB J"},{"key":"4431_CR40","doi-asserted-by":"publisher","first-page":"105663","DOI":"10.1016\/j.intimp.2019.05.048","volume":"74","author":"L Guo","year":"2019","unstructured":"Guo L, Lai P, Wang Y, Huang T, Chen X, Luo C, et al. Extracellular vesicles from mesenchymal stem cells prevent contact hypersensitivity through the suppression of Tc1 and Th1 cells and expansion of regulatory T cells. Int Immunopharmacol. 2019;74:105663.","journal-title":"Int Immunopharmacol"},{"key":"4431_CR41","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/nri.2017.24","volume":"17","author":"DJ Rawlings","year":"2017","unstructured":"Rawlings DJ, Metzler G, Wray-Dutra M, Jackson SW. Altered B cell signalling in autoimmunity. Nat Rev Immunol. 2017;17:421\u201336.","journal-title":"Nat Rev Immunol"},{"key":"4431_CR42","doi-asserted-by":"publisher","first-page":"395","DOI":"10.2337\/db07-0589","volume":"57","author":"E Mari\u00f1o","year":"2008","unstructured":"Mari\u00f1o E, Batten M, Groom J, Walters S, Liuwantara D, Mackay F, et al. Marginal-zone B-cells of nonobese diabetic mice expand with diabetes onset, invade the pancreatic lymph nodes, and present autoantigen to diabetogenic T-cells. Diabetes. 2008;57:395\u2013404.","journal-title":"Diabetes"},{"key":"4431_CR43","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/nri2729","volume":"10","author":"FE Lund","year":"2010","unstructured":"Lund FE, Randall TD. Effector and regulatory B cells: modulators of CD4+ T cell immunity. Nat Rev Immunol. 2010;10:236\u201347.","journal-title":"Nat Rev Immunol"},{"key":"4431_CR44","doi-asserted-by":"publisher","first-page":"108505","DOI":"10.1016\/j.isci.2023.108505","volume":"26","author":"S Liu","year":"2023","unstructured":"Liu S, Liu Z-C, Zhang M-Y, Wang S-J, Pan M, Ji P, et al. ICAM-1 mediated cell-cell adhesion exerts dual roles on human B cell differentiation and IgG production. iScience. 2023;26:108505.","journal-title":"iScience"},{"key":"4431_CR45","doi-asserted-by":"publisher","first-page":"909","DOI":"10.2337\/db07-1256","volume":"57","author":"GM Brodie","year":"2008","unstructured":"Brodie GM, Wallberg M, Santamaria P, Wong FS, Green EA. B-cells promote intra-islet CD8+ cytotoxic T-cell survival to enhance type 1 diabetes. Diabetes. 2008;57:909\u201317.","journal-title":"Diabetes"},{"key":"4431_CR46","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","volume":"107","author":"A Corcione","year":"2006","unstructured":"Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, et al. Human mesenchymal stem cells modulate B-cell functions. Blood. 2006;107:367\u201372.","journal-title":"Blood"},{"key":"4431_CR47","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1634\/stemcells.2007-0528","volume":"26","author":"E Traggiai","year":"2008","unstructured":"Traggiai E, Volpi S, Schena F, Gattorno M, Ferlito F, Moretta L, et al. Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells. 2008;26:562\u20139.","journal-title":"Stem Cells"},{"key":"4431_CR48","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3390\/cells13010080","volume":"13","author":"D-K Kim","year":"2023","unstructured":"Kim D-K, Lee H-J, Lee IH, Lee J-J. Immunomodulatory effects of primed tonsil-derived mesenchymal stem cells on atopic dermatitis via B cell regulation. Cells. 2023;13:80.","journal-title":"Cells"},{"key":"4431_CR49","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1097\/HEP.0000000000000831","volume":"81","author":"X Feng","year":"2025","unstructured":"Feng X, Feng B, Zhou J, Yang J, Pan Q, Yu J, et al. Mesenchymal stem cells alleviate mouse liver fibrosis by inhibiting pathogenic function of intrahepatic B cells. Hepatology. 2025;81:1211\u201327.","journal-title":"Hepatology"},{"key":"4431_CR50","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/leu.2014.225","volume":"29","author":"Y Peng","year":"2015","unstructured":"Peng Y, Chen X, Liu Q, Zhang X, Huang K, Liu L, et al. Mesenchymal stromal cells infusions improve refractory chronic graft versus host disease through an increase of CD5+ regulatory B cells producing interleukin 10. Leukemia. 2015;29:636\u201346.","journal-title":"Leukemia"},{"key":"4431_CR51","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00262-016-1820-y","volume":"65","author":"J Zong","year":"2016","unstructured":"Zong J, Keskinov AA, Shurin GV, Shurin MR. Tumor-derived factors modulating dendritic cell function. Cancer Immunol Immunother CII. 2016;65:821\u201333.","journal-title":"Cancer Immunol Immunother CII"},{"key":"4431_CR52","doi-asserted-by":"publisher","first-page":"650","DOI":"10.3390\/ijms17050650","volume":"17","author":"L Fan","year":"2016","unstructured":"Fan L, Hu C, Chen J, Cen P, Wang J, Li L. Interaction between mesenchymal stem cells and B-cells. Int J Mol Sci. 2016;17:650.","journal-title":"Int J Mol Sci"},{"key":"4431_CR53","doi-asserted-by":"publisher","first-page":"947823","DOI":"10.3389\/fonc.2022.947823","volume":"12","author":"J Ceccato","year":"2022","unstructured":"Ceccato J, Piazza M, Pizzi M, Manni S, Piazza F, Caputo I, et al. A bone-based 3D scaffold as an in-vitro model of microenvironment-DLBCL lymphoma cell interaction. Front Oncol. 2022;12:947823.","journal-title":"Front Oncol"},{"key":"4431_CR54","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/s42003-023-05374-0","volume":"6","author":"K Nakashima","year":"2023","unstructured":"Nakashima K, Kunisaki Y, Hosokawa K, Gotoh K, Yao H, Yuta R, et al. POT1a deficiency in mesenchymal niches perturbs B-lymphopoiesis. Commun Biol. 2023;6:996.","journal-title":"Commun Biol"},{"key":"4431_CR55","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13287-023-03432-2","volume":"14","author":"F Guo","year":"2023","unstructured":"Guo F, Pan Q, Chen T, Liao S, Li S, Li A, et al. hUC-MSC transplantation therapy effects on lupus-prone MRL\/lpr mice at early disease stages. Stem Cell Res Ther. 2023;14:211.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR56","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/nri3477","volume":"13","author":"D Ganguly","year":"2013","unstructured":"Ganguly D, Haak S, Sisirak V, Reizis B. The role of dendritic cells in autoimmunity. Nat Rev Immunol. 2013;13:566\u201377.","journal-title":"Nat Rev Immunol"},{"key":"4431_CR57","doi-asserted-by":"publisher","first-page":"2588","DOI":"10.2337\/diabetes.53.10.2588","volume":"53","author":"C Haase","year":"2004","unstructured":"Haase C, Skak K, Michelsen BK, Markholst H. Local activation of dendritic cells leads to insulitis and development of insulin-dependent diabetes in transgenic mice expressing CD154 on the pancreatic beta-cells. Diabetes. 2004;53:2588\u201395.","journal-title":"Diabetes"},{"key":"4431_CR58","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/nm.3042","volume":"19","author":"J Diana","year":"2013","unstructured":"Diana J, Simoni Y, Furio L, Beaudoin L, Agerberth B, Barrat F, et al. Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes. Nat Med. 2013;19:65\u201373.","journal-title":"Nat Med"},{"key":"4431_CR59","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00125-015-3808-0","volume":"59","author":"E Favaro","year":"2016","unstructured":"Favaro E, Carpanetto A, Caorsi C, Giovarelli M, Angelini C, Cavallo-Perin P, et al. Human mesenchymal stem cells and derived extracellular vesicles induce regulatory dendritic cells in type 1 diabetic patients. Diabetologia. 2016;59:325\u201333.","journal-title":"Diabetologia"},{"key":"4431_CR60","doi-asserted-by":"publisher","first-page":"1284936","DOI":"10.3389\/fimmu.2023.1284936","volume":"14","author":"Y Jiang","year":"2023","unstructured":"Jiang Y, Zhao J, Wang M, Huang F, Li J, Liu R, et al. Mesenchymal stem cell-derived exosomes can alleviate GVHD and preserve the GVL effect in allogeneic stem cell transplantation animal models. Front Immunol. 2023;14:1284936.","journal-title":"Front Immunol"},{"key":"4431_CR61","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12967-020-02410-z","volume":"18","author":"Z Lu","year":"2020","unstructured":"Lu Z, Meng S, Chang W, Fan S, Xie J, Guo F, et al. Mesenchymal stem cells activate Notch signaling to induce regulatory dendritic cells in LPS-induced acute lung injury. J Transl Med. 2020;18:241.","journal-title":"J Transl Med"},{"key":"4431_CR62","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1634\/stemcells.2008-0146","volume":"26","author":"H Li","year":"2008","unstructured":"Li H, Guo Z, Jiang X, Zhu H, Li X, Mao N. Mesenchymal stem cells alter migratory property of T and dendritic cells to delay the development of murine lethal acute graft-versus-host disease. Stem Cells. 2008;26:2531\u201341.","journal-title":"Stem Cells"},{"key":"4431_CR63","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.3389\/fimmu.2018.02538","volume":"9","author":"M Reis","year":"2018","unstructured":"Reis M, Mavin E, Nicholson L, Green K, Dickinson AM, Wang X. Mesenchymal stromal cell-derived extracellular vesicles attenuate dendritic cell maturation and function. Front Immunol. 2018;9:2538.","journal-title":"Front Immunol"},{"key":"4431_CR64","doi-asserted-by":"publisher","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1\/M2 polarization. Eur J Pharmacol. 2020;877:173090.","journal-title":"Eur J Pharmacol"},{"key":"4431_CR65","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.actbio.2020.12.046","volume":"122","author":"Y Nakao","year":"2021","unstructured":"Nakao Y, Fukuda T, Zhang Q, Sanui T, Shinjo T, Kou X, et al. Exosomes from TNF-\u03b1-treated human gingiva-derived MSCs enhance M2 macrophage polarization and inhibit periodontal bone loss. Acta Biomater. 2021;122:306\u201324.","journal-title":"Acta Biomater"},{"key":"4431_CR66","doi-asserted-by":"publisher","first-page":"851","DOI":"10.14336\/AD.2023.0719-1","volume":"15","author":"R Xue","year":"2024","unstructured":"Xue R, Xie M, Wu Z, Wang S, Zhang Y, Han Z, et al. Mesenchymal stem cell-derived exosomes promote recovery of the facial nerve injury through regulating macrophage M1 and M2 polarization by targeting the P38 MAPK\/NF-\u039ab pathway. Aging Dis. 2024;15:851\u201368.","journal-title":"Aging Dis"},{"key":"4431_CR67","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12933-025-02603-0","volume":"24","author":"L Liu","year":"2025","unstructured":"Liu L, An Z, Zhang H, Wan X, Zhao X, Yang X, et al. Bone marrow mesenchymal stem cell-derived extracellular vesicles alleviate diabetes-exacerbated atherosclerosis via AMPK\/mTOR pathway-mediated autophagy-related macrophage polarization. Cardiovasc Diabetol. 2025;24:48.","journal-title":"Cardiovasc Diabetol"},{"key":"4431_CR68","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41577-018-0056-9","volume":"18","author":"A Lapenna","year":"2018","unstructured":"Lapenna A, De Palma M, Lewis CE. Perivascular macrophages in health and disease. Nat Rev Immunol. 2018;18:689\u2013702.","journal-title":"Nat Rev Immunol"},{"key":"4431_CR69","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s13287-019-1332-8","volume":"10","author":"Y Yao","year":"2019","unstructured":"Yao Y, Chen R, Wang G, Zhang Y, Liu F. Exosomes derived from mesenchymal stem cells reverse EMT via TGF-\u03b21\/Smad pathway and promote repair of damaged endometrium. Stem Cell Res Ther. 2019;10:225.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR70","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s13287-020-01723-6","volume":"11","author":"T Jiang","year":"2020","unstructured":"Jiang T, Wang Z, Sun J. Human bone marrow mesenchymal stem cell-derived exosomes stimulate cutaneous wound healing mediates through TGF-\u03b2\/Smad signaling pathway. Stem Cell Res Ther. 2020;11:198.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR71","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s10565-022-09748-8","volume":"39","author":"K Geng","year":"2023","unstructured":"Geng K, Ma X, Jiang Z, Gu J, Huang W, Wang W, et al. WDR74 facilitates TGF-\u03b2\/Smad pathway activation to promote M2 macrophage polarization and diabetic foot ulcer wound healing in mice. Cell Biol Toxicol. 2023;39:1577\u201391.","journal-title":"Cell Biol Toxicol"},{"key":"4431_CR72","doi-asserted-by":"publisher","first-page":"1422355","DOI":"10.3389\/fimmu.2024.1422355","volume":"15","author":"Z Nie","year":"2024","unstructured":"Nie Z, Fan Q, Jiang W, Wei S, Luo R, Hu H, et al. Placental mesenchymal stem cells suppress inflammation and promote M2-like macrophage polarization through the IL-10\/STAT3\/NLRP3 axis in acute lung injury. Front Immunol. 2024;15:1422355.","journal-title":"Front Immunol"},{"key":"4431_CR73","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1186\/s12951-025-03250-z","volume":"23","author":"Q Qin","year":"2025","unstructured":"Qin Q, Fan L, Zeng X, Zheng D, Wang H, Li M, et al. Mesenchymal stem cell-derived extracellular vesicles alleviate autism by regulating microglial glucose metabolism reprogramming and neuroinflammation through PD-1\/PD-L1 interaction. J Nanobiotechnol. 2025;23:201.","journal-title":"J Nanobiotechnol"},{"issue":"186","key":"4431_CR74","first-page":"3093","volume":"2011","author":"Y Zhang","year":"1950","unstructured":"Zhang Y, Ma CJ, Ni L, Zhang CL, Wu XY, Kumaraguru U, et al. Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes\/macrophages in hepatitis C virus infection. J Immunol. 1950;2011(186):3093\u2013103.","journal-title":"J Immunol"},{"key":"4431_CR75","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1186\/s13287-024-03926-7","volume":"15","author":"J He","year":"2024","unstructured":"He J, Ao C, Li M, Deng T, Zheng S, Zhang K, et al. Clusterin-carrying extracellular vesicles derived from human umbilical cord mesenchymal stem cells restore the ovarian function of premature ovarian failure mice through activating the PI3K\/AKT pathway. Stem Cell Res Ther. 2024;15:300.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR76","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13287-022-02832-0","volume":"13","author":"A Aierken","year":"2022","unstructured":"Aierken A, Li B, Liu P, Cheng X, Kou Z, Tan N, et al. Melatonin treatment improves human umbilical cord mesenchymal stem cell therapy in a mouse model of type II diabetes mellitus via the PI3K\/AKT signaling pathway. Stem Cell Res Ther. 2022;13:164.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR77","doi-asserted-by":"publisher","first-page":"116938","DOI":"10.1016\/j.biopha.2024.116938","volume":"176","author":"Y Ding","year":"2024","unstructured":"Ding Y, Chen Q. Recent advances on signaling pathways and their inhibitors in spinal cord injury. Biomed Pharmacother. 2024;176:116938.","journal-title":"Biomed Pharmacother"},{"key":"4431_CR78","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ecl.2023.09.004","volume":"53","author":"R Longendyke","year":"2024","unstructured":"Longendyke R, Grundman JB, Majidi S. Acute and chronic adverse outcomes of type 1 diabetes. Endocrinol Metab Clin. 2024;53:123\u201333.","journal-title":"Endocrinol Metab Clin"},{"key":"4431_CR79","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/cells12030467","volume":"12","author":"G Obasanmi","year":"2023","unstructured":"Obasanmi G, Lois N, Armstrong D, Hombrebueno JMR, Lynch A, Chen M, et al. Peripheral blood mononuclear cells from patients with type 1 diabetes and diabetic retinopathy produce higher levels of IL-17A, IL-10 and IL-6 and lower levels of IFN-\u03b3\u2014A pilot study. Cells. 2023;12:467.","journal-title":"Cells"},{"key":"4431_CR80","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13287-022-02927-8","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Chen J, Liang H, Cai Y, Li X, Yan L, et al. Human umbilical cord-derived mesenchymal stem cells not only ameliorate blood glucose but also protect vascular endothelium from diabetic damage through a paracrine mechanism mediated by MAPK\/ERK signaling. Stem Cell Res Ther. 2022;13:258.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR81","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/s13287-022-02983-0","volume":"13","author":"F Sun","year":"2022","unstructured":"Sun F, Sun Y, Zhu J, Wang X, Ji C, Zhang J, et al. Mesenchymal stem cells-derived small extracellular vesicles alleviate diabetic retinopathy by delivering NEDD4. Stem Cell Res Ther. 2022;13:293.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR82","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/stmcls\/sxad078","volume":"42","author":"Y Chen","year":"2024","unstructured":"Chen Y, Yao G, Tong J, Xie H, Zheng X, Zhang H, et al. MSC-derived small extracellular vesicles alleviate diabetic retinopathy by delivering miR-22-3p to inhibit NLRP3 inflammasome activation. Stem Cells. 2024;42:64\u201375.","journal-title":"Stem Cells"},{"key":"4431_CR83","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/s41572-019-0097-9","volume":"5","author":"EL Feldman","year":"2019","unstructured":"Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nat Rev Dis Prim. 2019;5:42.","journal-title":"Nat Rev Dis Prim"},{"key":"4431_CR84","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S1474-4422(12)70065-0","volume":"11","author":"BC Callaghan","year":"2012","unstructured":"Callaghan BC, Cheng H, Stables CL, Smith AL, Feldman EL. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11:521\u201334.","journal-title":"Lancet Neurol"},{"key":"4431_CR85","doi-asserted-by":"publisher","first-page":"6897056","DOI":"10.1155\/2022\/6897056","volume":"2022","author":"S Pan","year":"2022","unstructured":"Pan S, Hada SS, Liu Y, Hu C, Zhou M, Zheng S, et al. Human placenta-derived mesenchymal stem cells ameliorate diabetic neuropathy via Wnt signaling pathway. Stem Cells Int. 2022;2022:6897056.","journal-title":"Stem Cells Int"},{"key":"4431_CR86","doi-asserted-by":"publisher","first-page":"103432","DOI":"10.1016\/j.etap.2020.103432","volume":"79","author":"D He","year":"2020","unstructured":"He D, Xu Y, Xiong X, Yin C, Lei S, Cheng X. The bone marrow-derived mesenchymal stem cells (BMSCs) alleviate diabetic peripheral neuropathy induced by STZ via activating GSK-3\u03b2\/\u03b2-catenin signaling pathway. Environ Toxicol Pharmacol. 2020;79:103432.","journal-title":"Environ Toxicol Pharmacol"},{"key":"4431_CR87","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00125-019-05043-0","volume":"63","author":"B Fan","year":"2020","unstructured":"Fan B, Li C, Szalad A, Wang L, Pan W, Zhang R, et al. Mesenchymal stromal cell-derived exosomes ameliorate peripheral neuropathy in a mouse model of diabetes. Diabetologia. 2020;63:431\u201343.","journal-title":"Diabetologia"},{"key":"4431_CR88","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.3390\/nu15234914","volume":"15","author":"MC Andreo-L\u00f3pez","year":"2023","unstructured":"Andreo-L\u00f3pez MC, Zarco-Mart\u00edn MT, Contreras-Bol\u00edvar V, Fern\u00e1ndez-Soto ML. Prevalence of sarcopenia and dynapenia and related clinical outcomes in patients with type 1 diabetes mellitus. Nutrients. 2023;15:4914.","journal-title":"Nutrients"},{"key":"4431_CR89","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/mus.26196","volume":"58","author":"MA Sabadine","year":"2018","unstructured":"Sabadine MA, Russo TL, Luna GF, Oliveira Leal AM. Effects of mesenchymal stromal cells on type 1 diabetes mellitus rat muscles. Muscle Nerve. 2018;58:583\u201391.","journal-title":"Muscle Nerve"},{"key":"4431_CR90","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1002\/jcsm.13177","volume":"14","author":"J Song","year":"2023","unstructured":"Song J, Liu J, Cui C, Hu H, Zang N, Yang M, et al. Mesenchymal stromal cells ameliorate diabetes-induced muscle atrophy through exosomes by enhancing AMPK\/ULK1-mediated autophagy. J Cachexia Sarcopenia Muscle. 2023;14:915\u201329.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"4431_CR91","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","volume":"17","author":"Y Tan","year":"2020","unstructured":"Tan Y, Zhang Z, Zheng C, Wintergerst KA, Keller BB, Cai L. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence. Nat Rev Cardiol. 2020;17:585\u2013607.","journal-title":"Nat Rev Cardiol"},{"key":"4431_CR92","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13287-021-02332-7","volume":"12","author":"A Tamara","year":"2021","unstructured":"Tamara A, Coulson DJ, Latief JS, Bakhashab S, Weaver JU. Upregulated anti-angiogenic miR-424-5p in type 1 diabetes (model of subclinical cardiovascular disease) correlates with endothelial progenitor cells, CXCR1\/2 and other parameters of vascular health. Stem Cell Res Ther. 2021;12:249.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR93","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13287-023-03269-9","volume":"14","author":"X Bian","year":"2023","unstructured":"Bian X, Conley SM, Eirin A, Zimmerman Zuckerman EA, Smith AL, Gowan CC, et al. Diabetic kidney disease induces transcriptome alterations associated with angiogenesis activity in human mesenchymal stromal cells. Stem Cell Res Ther. 2023;14:49.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR94","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13287-025-04207-7","volume":"16","author":"Q Deng","year":"2025","unstructured":"Deng Q, Du F, Pan S, Xia Y, Zhu Y, Zhang J, et al. Activation of angiopoietin-1 signaling with engineering mesenchymal stem cells promoted efficient angiogenesis in diabetic wound healing. Stem Cell Res Ther. 2025;16:75.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR95","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1001\/jama.2023.17291","volume":"330","author":"R Voelker","year":"2023","unstructured":"Voelker R. What are diabetic foot ulcers? JAMA. 2023;330:2314.","journal-title":"JAMA"},{"key":"4431_CR96","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13287-025-04141-8","volume":"16","author":"J Huang","year":"2025","unstructured":"Huang J, Deng Q, Tsang LL, Chang G, Guo J, Ruan YC, et al. Mesenchymal stem cells from perinatal tissues promote diabetic wound healing via PI3K\/AKT activation. Stem Cell Res Ther. 2025;16:59.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR97","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1093\/abbs\/gmaa039","volume":"52","author":"R Shi","year":"2020","unstructured":"Shi R, Lian W, Jin Y, Cao C, Han S, Yang X, et al. Role and effect of vein-transplanted human umbilical cord mesenchymal stem cells in the repair of diabetic foot ulcers in rats. Acta Biochim Biophys Sin. 2020;52:620\u201330.","journal-title":"Acta Biochim Biophys Sin"},{"key":"4431_CR98","doi-asserted-by":"publisher","first-page":"117955141984452","DOI":"10.1177\/1179551419844521","volume":"12","author":"V Pathak","year":"2019","unstructured":"Pathak V, Pathak NM, O\u2019Neill CL, Guduric-Fuchs J, Medina RJ. Therapies for type 1 diabetes: current scenario and future perspectives. Clin Med Insights Endocrinol Diabetes. 2019;12:1179551419844521.","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"4431_CR99","doi-asserted-by":"publisher","first-page":"230","DOI":"10.7705\/biomedica.v36i2.2686","volume":"36","author":"L Bequer","year":"2016","unstructured":"Bequer L, G\u00f3mez T, Molina JL, Artiles D, Berm\u00fadez R, Clap\u00e9s S. Streptozotocin diabetogenic action in an experimental neonatal induction model. Biomedica. 2016;36:230\u20138.","journal-title":"Biomedica"},{"key":"4431_CR100","doi-asserted-by":"publisher","first-page":"e78","DOI":"10.1002\/cpz1.78","volume":"1","author":"BL Furman","year":"2021","unstructured":"Furman BL. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc. 2021;1:e78.","journal-title":"Curr Protoc"},{"key":"4431_CR101","doi-asserted-by":"publisher","first-page":"719","DOI":"10.4314\/ahs.v21i2.30","volume":"21","author":"OM Akinlade","year":"2021","unstructured":"Akinlade OM, Owoyele BV, Soladoye AO. Streptozotocin-induced type 1 and 2 diabetes in rodents: a model for studying diabetic cardiac autonomic neuropathy. Afr Health Sci. 2021;21:719\u201327.","journal-title":"Afr Health Sci"},{"key":"4431_CR102","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.vascn.2015.11.004","volume":"78","author":"M Radenkovi\u0107","year":"2016","unstructured":"Radenkovi\u0107 M, Stojanovi\u0107 M, Prostran M. Experimental diabetes induced by alloxan and streptozotocin: the current state of the art. J Pharmacol Toxicol Methods. 2016;78:13\u201331.","journal-title":"J Pharmacol Toxicol Methods"},{"key":"4431_CR103","doi-asserted-by":"publisher","first-page":"149452","DOI":"10.1155\/2013\/149452","volume":"2013","author":"MS Islam","year":"2013","unstructured":"Islam MS. Animal models of diabetic neuropathy: progress since 1960s. J Diabetes Res. 2013;2013:149452.","journal-title":"J Diabetes Res"},{"key":"4431_CR104","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/S0024-3205(02)01918-5","volume":"71","author":"SS im Walde","year":"2022","unstructured":"im Walde SS, Dohle C, Schott-Ohly P, Gleichmann H. Molecular target structures in alloxan-induced diabetes in mice. Life Sci. 2022;71:1681\u201394.","journal-title":"Life Sci"},{"issue":"160","key":"4431_CR105","first-page":"5838","volume":"1998","author":"NN Iwakoshi","year":"1950","unstructured":"Iwakoshi NN, Goldschneider I, Tausche F, Mordes JP, Rossini AA, Greiner DL. High frequency apoptosis of recent thymic emigrants in the liver of lymphopenic diabetes-prone BioBreeding rats. J Immunol. 1950;1998(160):5838\u201350.","journal-title":"J Immunol"},{"key":"4431_CR106","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/978-1-0716-0385-7_6","volume":"2128","author":"D Chen","year":"2020","unstructured":"Chen D, Thayer TC, Wen L, Wong FS. Mouse models of autoimmune diabetes: the nonobese diabetic (NOD) mouse. Methods Mol Biol. 2020;2128:87\u201392.","journal-title":"Methods Mol Biol"},{"key":"4431_CR107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1196\/annals.1394.018","volume":"1103","author":"BO Roep","year":"2007","unstructured":"Roep BO. Are insights gained from NOD mice sufficient to guide clinical translation? Another inconvenient truth. Ann N Y Acad Sci. 2007;1103:1\u201310.","journal-title":"Ann N Y Acad Sci"},{"key":"4431_CR108","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00281-010-0204-1","volume":"33","author":"JP Driver","year":"2011","unstructured":"Driver JP, Serreze DV, Chen Y-G. Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease. Semin Immunopathol. 2011;33:67\u201387.","journal-title":"Semin Immunopathol"},{"key":"4431_CR109","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1172\/JCI119733","volume":"100","author":"N Yokoi","year":"1997","unstructured":"Yokoi N, Kanazawa M, Kitada K, Tanaka A, Kanazawa Y, Suda S, et al. A non-MHC locus essential for autoimmune type I diabetes in the Komeda Diabetes-Prone rat. J Clin Invest. 1997;100:2015\u201321.","journal-title":"J Clin Invest"},{"key":"4431_CR110","doi-asserted-by":"publisher","first-page":"14106","DOI":"10.1038\/s41598-018-32546-4","volume":"8","author":"J Verhagen","year":"2018","unstructured":"Verhagen J, Smith EL, Whettlock EM, Macintyre B, Peakman M. Proinsulin-mediated induction of type 1 diabetes in HLA-DR4-transgenic mice. Sci Rep. 2018;8:14106.","journal-title":"Sci Rep"},{"key":"4431_CR111","doi-asserted-by":"publisher","first-page":"748679","DOI":"10.3389\/fimmu.2021.748679","volume":"12","author":"S Luce","year":"2021","unstructured":"Luce S, Guinoiseau S, Gadault A, Letourneur F, Nitschke P, Bras M, et al. A humanized mouse strain that develops spontaneously immune-mediated diabetes. Front Immunol. 2021;12:748679.","journal-title":"Front Immunol"},{"key":"4431_CR112","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1023\/A:1021144209209","volume":"11","author":"U Christen","year":"2002","unstructured":"Christen U, von Herrath MG. Transgenic animal models for type 1 diabetes: linking a tetracycline-inducible promoter with a virus-inducible mouse model. Transgenic Res. 2002;11:587\u201395.","journal-title":"Transgenic Res"},{"key":"4431_CR113","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1600-065X.1999.tb01306.x","volume":"169","author":"A Suri","year":"1999","unstructured":"Suri A, Katz JD. Dissecting the role of CD4+ T cells in autoimmune diabetes through the use of TCR transgenic mice. Immunol Rev. 1999;169:55\u201365.","journal-title":"Immunol Rev"},{"issue":"183","key":"4431_CR114","first-page":"993","volume":"2009","author":"P Fiorina","year":"1950","unstructured":"Fiorina P, Jurewicz M, Augello A, Vergani A, Dada S, La Rosa S, et al. Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol. 1950;2009(183):993\u20131004.","journal-title":"J Immunol"},{"key":"4431_CR115","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1084\/jem.20022125","volume":"198","author":"MJI Ansari","year":"2003","unstructured":"Ansari MJI, Salama AD, Chitnis T, Smith RN, Yagita H, Akiba H, et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J Exp Med. 2003;198:63\u20139.","journal-title":"J Exp Med"},{"key":"4431_CR116","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s00125-022-05708-3","volume":"65","author":"E Kawada-Horitani","year":"2022","unstructured":"Kawada-Horitani E, Kita S, Okita T, Nakamura Y, Nishida H, Honma Y, et al. Human adipose-derived mesenchymal stem cells prevent type 1 diabetes induced by immune checkpoint blockade. Diabetologia. 2022;65:1185\u201397.","journal-title":"Diabetologia"},{"key":"4431_CR117","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1007\/s00125-009-1374-z","volume":"52","author":"AM Madec","year":"2009","unstructured":"Madec AM, Mallone R, Afonso G, Abou Mrad E, Mesnier A, Eljaafari A, et al. Mesenchymal stem cells protect NOD mice from diabetes by inducing regulatory T cells. Diabetologia. 2009;52:1391\u20139.","journal-title":"Diabetologia"},{"key":"4431_CR118","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s13287-022-02974-1","volume":"13","author":"W Zhang","year":"2022","unstructured":"Zhang W, Ling Q, Wang B, Wang K, Pang J, Lu J, et al. Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes. Stem Cell Res Ther. 2022;13:406.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR119","doi-asserted-by":"publisher","first-page":"4775285","DOI":"10.1155\/2024\/4775285","volume":"2024","author":"Y Ou","year":"2024","unstructured":"Ou Y, Yang Y, Wang Y, Su H, Zhou Y-K. Effects of extracellular vesicles derived from human umbilical cord blood mesenchymal stem cells on cell immunity in nonobese mice. Stem Cells Int. 2024;2024:4775285.","journal-title":"Stem Cells Int"},{"key":"4431_CR120","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1111\/iep.12340","volume":"100","author":"GLF Luna","year":"2019","unstructured":"Luna GLF, Russo TL, Sabadine MA, Estrada-Bonilla YC, Andrade ALM, Brassolatti P, et al. Effects of mesenchymal stromal cells on motor function and collagen in the skeletal muscles of rats with type I diabetes. Int J Exp Pathol. 2019;100:359\u201368.","journal-title":"Int J Exp Pathol"},{"key":"4431_CR121","doi-asserted-by":"publisher","first-page":"6877","DOI":"10.3390\/ijms23136877","volume":"23","author":"YM Park","year":"2022","unstructured":"Park YM, Yang CM, Cho HY. Therapeutic effects of insulin-producing human umbilical cord-derived mesenchymal stem cells in a type 1 diabetes mouse model. Int J Mol Sci. 2022;23:6877.","journal-title":"Int J Mol Sci"},{"key":"4431_CR122","doi-asserted-by":"publisher","first-page":"e0186637","DOI":"10.1371\/journal.pone.0186637","volume":"12","author":"N Murai","year":"2017","unstructured":"Murai N, Ohtaki H, Watanabe J, Xu Z, Sasaki S, Yagura K, et al. Intrapancreatic injection of human bone marrow-derived mesenchymal stem\/stromal cells alleviates hyperglycemia and modulates the macrophage state in streptozotocin-induced type 1 diabetic mice. PLoS ONE. 2017;12:e0186637.","journal-title":"PLoS ONE"},{"key":"4431_CR123","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1093\/stcltm\/szae020","volume":"13","author":"R Primavera","year":"2024","unstructured":"Primavera R, Regmi S, Yarani R, Levitte S, Wang J, Ganguly A, et al. Precision delivery of human bone marrow-derived mesenchymal stem cells into the pancreas via intra-arterial injection prevents the onset of diabetes. Stem Cells Transl Med. 2024;13:559\u201371.","journal-title":"Stem Cells Transl Med"},{"key":"4431_CR124","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1007\/s00125-013-3109-4","volume":"57","author":"DJ Borg","year":"2014","unstructured":"Borg DJ, Weigelt M, Wilhelm C, Gerlach M, Bickle M, Speier S, et al. Mesenchymal stromal cells improve transplanted islet survival and islet function in a syngeneic mouse model. Diabetologia. 2014;57:522\u201331.","journal-title":"Diabetologia"},{"key":"4431_CR125","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.intimp.2017.01.019","volume":"44","author":"S Daneshmandi","year":"2017","unstructured":"Daneshmandi S, Karimi MH, Pourfathollah AA. TGF-\u03b2 engineered mesenchymal stem cells (TGF-\u03b2\/MSCs) for treatment of Type 1 diabetes (T1D) mice model. Int Immunopharmacol. 2017;44:191\u20136.","journal-title":"Int Immunopharmacol"},{"key":"4431_CR126","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1007\/s10529-020-02908-y","volume":"42","author":"D Sabry","year":"2020","unstructured":"Sabry D, Marzouk S, Zakaria R, Ibrahim HA, Samir M. The effect of exosomes derived from mesenchymal stem cells in the treatment of induced type 1 diabetes mellitus in rats. Biotechnol Lett. 2020;42:1597\u2013610.","journal-title":"Biotechnol Lett"},{"key":"4431_CR127","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1242\/dmm.010389","volume":"6","author":"P Bonaldo","year":"2013","unstructured":"Bonaldo P, Sandri M. Cellular and molecular mechanisms of muscle atrophy. Dis Model Mech. 2013;6:25\u201339.","journal-title":"Dis Model Mech"},{"key":"4431_CR128","doi-asserted-by":"publisher","first-page":"3876","DOI":"10.7150\/thno.19547","volume":"7","author":"J Hedhli","year":"2017","unstructured":"Hedhli J, Konopka CJ, Schuh S, Bouvin H, Cole JA, Huntsman HD, et al. Multimodal assessment of mesenchymal stem cell therapy for diabetic vascular complications. Theranostics. 2017;7:3876\u201388.","journal-title":"Theranostics"},{"key":"4431_CR129","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s13287-025-04265-x","volume":"16","author":"R Li","year":"2025","unstructured":"Li R, Tao H, Pan K, Li R, Guo Z, Chen X, et al. Extracellular vesicles derived from mesenchymal stem cells alleviate renal fibrosis via the miR-99b-5p\/mTOR\/autophagy axis in diabetic kidney disease. Stem Cell Res Ther. 2025;16:142.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR130","doi-asserted-by":"publisher","first-page":"3788","DOI":"10.1210\/jc.2009-2350","volume":"95","author":"MM Zanone","year":"2010","unstructured":"Zanone MM, Favaro E, Miceli I, Grassi G, Camussi E, Caorsi C, et al. Human mesenchymal stem cells modulate cellular immune response to islet antigen glutamic acid decarboxylase in type 1 diabetes. J Clin Endocrinol Metab. 2010;95:3788\u201397.","journal-title":"J Clin Endocrinol Metab"},{"key":"4431_CR131","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.gene.2018.02.008","volume":"654","author":"MG Amer","year":"2018","unstructured":"Amer MG, Embaby AS, Karam RA, Amer MG. Role of adipose tissue derived stem cells differentiated into insulin producing cells in the treatment of type I diabetes mellitus. Gene. 2018;654:87\u201394.","journal-title":"Gene"},{"key":"4431_CR132","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature02520","volume":"429","author":"Y Dor","year":"2004","unstructured":"Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature. 2004;429:41\u20136.","journal-title":"Nature"},{"key":"4431_CR133","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbmt.2008.01.006","volume":"14","author":"FE Ezquer","year":"2008","unstructured":"Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Ya\u00f1ez AJ, Conget PA. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant. 2008;14:631\u201340.","journal-title":"Biol Blood Marrow Transplant"},{"key":"4431_CR134","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1089\/scd.2016.0022","volume":"25","author":"W-J Du","year":"2016","unstructured":"Du W-J, Reppel L, Leger L, Schenowitz C, Huselstein C, Bensoussan D, et al. Mesenchymal stem cells derived from human bone marrow and adipose tissue maintain their immunosuppressive properties after chondrogenic differentiation: role of HLA-G. Stem Cells Dev. 2016;25:1454\u201369.","journal-title":"Stem Cells Dev"},{"key":"4431_CR135","first-page":"557","volume":"16","author":"HM Lazarus","year":"1995","unstructured":"Lazarus HM, Haynesworth SE, Gerson SL, Rosenthal NS, Caplan AI. Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use. Bone Marrow Transplant. 1995;16:557\u201364.","journal-title":"Bone Marrow Transplant"},{"key":"4431_CR136","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13287-022-02941-w","volume":"13","author":"M Izadi","year":"2022","unstructured":"Izadi M, Sadr Hashemi Nejad A, Moazenchi M, Masoumi S, Rabbani A, Kompani F, et al. Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I\/II randomized placebo-controlled clinical trial. Stem Cell Res Ther. 2022;13:264.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR137","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13643-022-01950-3","volume":"11","author":"S Madani","year":"2022","unstructured":"Madani S, Amanzadi M, Aghayan HR, Setudeh A, Rezaei N, Rouhifard M, et al. Investigating the safety and efficacy of hematopoietic and mesenchymal stem cell transplantation for treatment of T1DM: a systematic review and meta-analysis. Syst Rev. 2022;11:82.","journal-title":"Syst Rev"},{"key":"4431_CR138","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jcyt.2021.09.015","volume":"24","author":"Z Wu","year":"2022","unstructured":"Wu Z, Xu X, Cai J, Chen J, Huang L, Wu W, et al. Prevention of chronic diabetic complications in type 1 diabetes by co-transplantation of umbilical cord mesenchymal stromal cells and autologous bone marrow: a pilot randomized controlled open-label clinical study with 8-year follow-up. Cytotherapy. 2022;24:421\u20137.","journal-title":"Cytotherapy"},{"key":"4431_CR139","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13287-022-02848-6","volume":"13","author":"L Zang","year":"2022","unstructured":"Zang L, Li Y, Hao H, Liu J, Cheng Y, Li B, et al. Efficacy and safety of umbilical cord-derived mesenchymal stem cells in Chinese adults with type 2 diabetes: a single-center, double-blinded, randomized, placebo-controlled phase II trial. Stem Cell Res Ther. 2022;13:180.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR140","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ijcard.2013.12.013","volume":"171","author":"G Monnerat-Cahli","year":"2014","unstructured":"Monnerat-Cahli G, Trentin-Sonoda M, Guerra B, Manso G, Ferreira ACF, Silva DLSG, et al. Bone marrow mesenchymal stromal cells rescue cardiac function in streptozotocin-induced diabetic rats. Int J Cardiol. 2014;171:199\u2013208.","journal-title":"Int J Cardiol"},{"key":"4431_CR141","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00125-023-05934-3","volume":"66","author":"P-O Carlsson","year":"2023","unstructured":"Carlsson P-O, Espes D, Sisay S, Davies LC, Smith CIE, Svahn MG. Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I\/II randomised double-blind placebo-controlled trial. Diabetologia. 2023;66:1431\u201341.","journal-title":"Diabetologia"},{"key":"4431_CR142","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2337\/db14-0656","volume":"64","author":"P-O Carlsson","year":"2015","unstructured":"Carlsson P-O, Schwarcz E, Korsgren O, Le Blanc K. Preserved \u03b2-cell function in type 1 diabetes by mesenchymal stromal cells. Diabetes. 2015;64:587\u201392.","journal-title":"Diabetes"},{"key":"4431_CR143","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1210\/clinem\/dgad068","volume":"108","author":"M Nwokolo","year":"2023","unstructured":"Nwokolo M, Hovorka R. The artificial pancreas and type 1 diabetes. J Clin Endocrinol Metab. 2023;108:1614\u201323.","journal-title":"J Clin Endocrinol Metab"},{"key":"4431_CR144","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.amjmed.2020.03.033","volume":"133","author":"S Ellahham","year":"2020","unstructured":"Ellahham S. Artificial intelligence: the future for diabetes care. Am J Med. 2020;133:895\u2013900.","journal-title":"Am J Med"},{"key":"4431_CR145","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1002\/stem.3378","volume":"39","author":"Y Wang","year":"2021","unstructured":"Wang Y, Wang J-W, Li Y, Tian X-H, Feng X-S, Zhang S-C, et al. Bone marrow-derived mesenchymal stem cells improve rat islet graft revascularization by upregulating ISL1. Stem Cells. 2021;39:1033\u201348.","journal-title":"Stem Cells"},{"key":"4431_CR146","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1177\/1535370219844472","volume":"244","author":"Y Tan","year":"2019","unstructured":"Tan Y, Nie W, Chen C, He X, Xu Y, Ma X, et al. Mesenchymal stem cells alleviate hypoxia-induced oxidative stress and enhance the pro-survival pathways in porcine islets. Exp Biol Med. 2019;244:781\u20138.","journal-title":"Exp Biol Med"},{"key":"4431_CR147","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3727\/215517917X693401","volume":"9","author":"SW Schive","year":"2017","unstructured":"Schive SW, Mirlashari MR, Hasvold G, Wang M, Josefsen D, Gullestad HP, et al. Human adipose-derived mesenchymal stem cells respond to short-term hypoxia by secreting factors beneficial for human islets in vitro and potentiate antidiabetic effect in vivo. Cell Med. 2017;9:103\u201316.","journal-title":"Cell Med"},{"key":"4431_CR148","doi-asserted-by":"publisher","first-page":"12204","DOI":"10.7150\/thno.47683","volume":"10","author":"J Xu","year":"2020","unstructured":"Xu J, Wang X, Chen J, Chen S, Li Z, Liu H, et al. Embryonic stem cell-derived mesenchymal stem cells promote colon epithelial integrity and regeneration by elevating circulating IGF-1 in colitis mice. Theranostics. 2020;10:12204\u201322.","journal-title":"Theranostics"},{"key":"4431_CR149","doi-asserted-by":"publisher","first-page":"e15227","DOI":"10.1111\/dme.15227","volume":"40","author":"T Hong","year":"2023","unstructured":"Hong T, Caxaria S, Daniels Gatward LF, Hussain S, Zhao M, King AJF, et al. Mesenchymal stromal cell secretory molecules improve the functional survival of human islets. Diabet Med. 2023;40:e15227.","journal-title":"Diabet Med"},{"key":"4431_CR150","doi-asserted-by":"publisher","first-page":"112613","DOI":"10.1016\/j.msec.2021.112613","volume":"133","author":"X Geng","year":"2022","unstructured":"Geng X, Qi Y, Liu X, Shi Y, Li H, Zhao L. A multifunctional antibacterial and self-healing hydrogel laden with bone marrow mesenchymal stem cell-derived exosomes for accelerating diabetic wound healing. Biomater Adv. 2022;133:112613.","journal-title":"Biomater Adv"},{"key":"4431_CR151","doi-asserted-by":"publisher","first-page":"5911","DOI":"10.2147\/IJN.S249129","volume":"15","author":"J Yang","year":"2020","unstructured":"Yang J, Chen Z, Pan D, Li H, Shen J. Umbilical cord-derived mesenchymal stem cell-derived exosomes combined pluronic F127 hydrogel promote chronic diabetic wound healing and complete skin regeneration. Int J Nanomed. 2020;15:5911\u201326.","journal-title":"Int J Nanomed"},{"key":"4431_CR152","doi-asserted-by":"publisher","first-page":"4796","DOI":"10.1007\/s12010-023-04532-8","volume":"195","author":"F Ahmadi","year":"2023","unstructured":"Ahmadi F, Lotfi AS, Navaei-Nigjeh M, Kadivar M. Trimetazidine preconditioning potentiates the effect of mesenchymal stem cells secretome on the preservation of rat pancreatic islet survival and function in vitro. Appl Biochem Biotechnol. 2023;195:4796\u2013817.","journal-title":"Appl Biochem Biotechnol"},{"key":"4431_CR153","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1186\/s13287-022-03218-y","volume":"13","author":"A Farid","year":"2022","unstructured":"Farid A, Haridyy H, Ashraf S, Ahmed S, Safwat G. Co-treatment with grape seed extract and mesenchymal stem cells in vivo regenerated beta cells of islets of Langerhans in pancreas of type I-induced diabetic rats. Stem Cell Res Ther. 2022;13:528.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR154","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/1471-2121-14-38","volume":"14","author":"YS Kim","year":"2013","unstructured":"Kim YS, Kwon JS, Hong MH, Kang WS, Jeong H, Kang H, et al. Restoration of angiogenic capacity of diabetes-insulted mesenchymal stem cells by oxytocin. BMC Cell Biol. 2013;14:38.","journal-title":"BMC Cell Biol"},{"key":"4431_CR155","doi-asserted-by":"publisher","first-page":"5362","DOI":"10.1039\/D0BM01076F","volume":"8","author":"X Li","year":"2020","unstructured":"Li X, Wei Z, Wu L, Lv H, Zhang Y, Li J, et al. Efficacy of Fe3O4@polydopamine nanoparticle-labeled human umbilical cord Wharton\u2019s jelly-derived mesenchymal stem cells in the treatment of streptozotocin-induced diabetes in rats. Biomater Sci. 2020;8:5362\u201375.","journal-title":"Biomater Sci"},{"key":"4431_CR156","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/biology13040253","volume":"13","author":"DY Khalil","year":"2024","unstructured":"Khalil DY, Hussein RH, El-Kholy WM. Mesenchymal stem cell-derived exosomes loaded with selenium or nano selenium as a novel therapeutic paradigm for streptozotocin-induced type 1 diabetes in rats. Biology. 2024;13:253.","journal-title":"Biology"},{"key":"4431_CR157","doi-asserted-by":"publisher","first-page":"3892","DOI":"10.1039\/C6TB00731G","volume":"4","author":"C-T Ma","year":"2016","unstructured":"Ma C-T, Wu Y-J, Huang HH, Kang P-L, Hsiao KY, Lo DY, et al. In vitro and in vivo evaluation of the effect of nano-sized collagen molecules and nicotinamide on mesenchymal stem cell differentiation. J Mater Chem B. 2016;4:3892\u2013902.","journal-title":"J Mater Chem B"},{"key":"4431_CR158","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.2337\/db20-0138","volume":"69","author":"K Kaushik","year":"2020","unstructured":"Kaushik K, Das A. TWIST1-reprogrammed endothelial cell transplantation potentiates neovascularization-mediated diabetic wound tissue regeneration. Diabetes. 2020;69:1232\u201347.","journal-title":"Diabetes"},{"key":"4431_CR159","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.3390\/bioengineering11121244","volume":"11","author":"Q Deng","year":"2024","unstructured":"Deng Q, Pan S, Du F, Sang H, Cai Z, Xu X, et al. The effect of conditioned medium from angiopoietin-1 gene-modified mesenchymal stem cells on wound healing in a diabetic mouse model. Bioengineering. 2024;11:1244.","journal-title":"Bioengineering"},{"key":"4431_CR160","doi-asserted-by":"publisher","first-page":"eabi4379","DOI":"10.1126\/sciadv.abi4379","volume":"7","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Gao S, Liang K, Wu Z, Yan X, Liu W, et al. Exendin-4 gene modification and microscaffold encapsulation promote self-persistence and antidiabetic activity of MSCs. Sci Adv. 2021;7:eabi4379.","journal-title":"Sci Adv"},{"key":"4431_CR161","first-page":"672013","volume":"2012","author":"Q-S Guo","year":"2012","unstructured":"Guo Q-S, Zhu M-Y, Wang L, Fan X-J, Lu Y-H, Wang Z-W, et al. Combined transfection of the three transcriptional factors, PDX-1, NeuroD1, and MafA, causes differentiation of bone marrow mesenchymal stem cells into insulin-producing cells. Exp Diabetes Res. 2012;2012:672013.","journal-title":"Exp Diabetes Res"},{"key":"4431_CR162","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1002\/sctm.18-0033","volume":"7","author":"AA Arzouni","year":"2018","unstructured":"Arzouni AA, Vargas-Seymour A, Nardi N, King JFA, Jones PM. Using mesenchymal stromal cells in islet transplantation. Stem Cells Transl Med. 2018;7:559\u201363.","journal-title":"Stem Cells Transl Med"},{"key":"4431_CR163","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrendo.2016.178","volume":"13","author":"AMJ Shapiro","year":"2017","unstructured":"Shapiro AMJ, Pokrywczynska M, Ricordi C. Clinical pancreatic islet transplantation. Nat Rev Endocrinol. 2017;13:268\u201377.","journal-title":"Nat Rev Endocrinol"},{"key":"4431_CR164","doi-asserted-by":"publisher","first-page":"966","DOI":"10.2337\/diabetes.51.4.966","volume":"51","author":"MK Lingohr","year":"2002","unstructured":"Lingohr MK, Dickson LM, McCuaig JF, Hugl SR, Twardzik DR, Rhodes CJ. Activation of IRS-2-mediated signal transduction by IGF-1, but not TGF-alpha or EGF, augments pancreatic beta-cell proliferation. Diabetes. 2002;51:966\u201376.","journal-title":"Diabetes"},{"key":"4431_CR165","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1007\/s10439-009-9892-x","volume":"38","author":"C An","year":"2010","unstructured":"An C, Cheng Y, Yuan Q, Li J. IGF-1 and BMP-2 induces differentiation of adipose-derived mesenchymal stem cells into chondrocytes-like cells. Ann Biomed Eng. 2010;38:1647\u201354.","journal-title":"Ann Biomed Eng"},{"key":"4431_CR166","doi-asserted-by":"publisher","first-page":"963689721107312","DOI":"10.1177\/09636897211073127","volume":"31","author":"L Wei","year":"2022","unstructured":"Wei L, Zhang L, Yang L, Wang X, Zhao C, Zhao D. Protective effect of mesenchymal stem cells on isolated islets survival and against hypoxia associated with the HIF-1\u03b1\/PFKFB3 pathway. Cell Transplant. 2022;31:9636897211073128.","journal-title":"Cell Transplant"},{"key":"4431_CR167","doi-asserted-by":"publisher","first-page":"655","DOI":"10.3390\/cells10030655","volume":"10","author":"J Holl","year":"2021","unstructured":"Holl J, Kowalewski C, Zimek Z, Fiedor P, Kaminski A, Oldak T, et al. Chronic diabetic wounds and their treatment with skin substitutes. Cells. 2021;10:655.","journal-title":"Cells"},{"key":"4431_CR168","doi-asserted-by":"publisher","first-page":"120608","DOI":"10.1016\/j.biomaterials.2020.120608","volume":"269","author":"T-Y Chen","year":"2021","unstructured":"Chen T-Y, Wen T-K, Dai N-T, Hsu S-H. Cryogel\/hydrogel biomaterials and acupuncture combined to promote diabetic skin wound healing through immunomodulation. Biomaterials. 2021;269:120608.","journal-title":"Biomaterials"},{"key":"4431_CR169","doi-asserted-by":"publisher","first-page":"2049","DOI":"10.1007\/s10439-016-1583-9","volume":"44","author":"W Gao","year":"2016","unstructured":"Gao W, Zhang Y, Zhang Q, Zhang L. Nanoparticle-hydrogel: a hybrid biomaterial system for localized drug delivery. Ann Biomed Eng. 2016;44:2049\u201361.","journal-title":"Ann Biomed Eng"},{"key":"4431_CR170","doi-asserted-by":"publisher","first-page":"7961","DOI":"10.1016\/j.biomaterials.2011.06.068","volume":"32","author":"J-H Jeong","year":"2011","unstructured":"Jeong J-H, Hong SW, Hong S, Yook S, Jung Y, Park J-B, et al. Surface camouflage of pancreatic islets using 6-arm-PEG-catechol in combined therapy with tacrolimus and anti-CD154 monoclonal antibody for xenotransplantation. Biomaterials. 2011;32:7961\u201370.","journal-title":"Biomaterials"},{"key":"4431_CR171","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.biomaterials.2016.11.004","volume":"114","author":"K Jiang","year":"2017","unstructured":"Jiang K, Weaver JD, Li Y, Chen X, Liang J, Stabler CL. Local release of dexamethasone from macroporous scaffolds accelerates islet transplant engraftment by promotion of anti-inflammatory M2 macrophages. Biomaterials. 2017;114:71\u201381.","journal-title":"Biomaterials"},{"key":"4431_CR172","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.addr.2019.01.013","volume":"139","author":"AU Ernst","year":"2019","unstructured":"Ernst AU, Bowers DT, Wang L-H, Shariati K, Plesser MD, Brown NK, et al. Nanotechnology in cell replacement therapies for type 1 diabetes. Adv Drug Deliv Rev. 2019;139:116\u201338.","journal-title":"Adv Drug Deliv Rev"},{"key":"4431_CR173","doi-asserted-by":"publisher","first-page":"181156","DOI":"10.1098\/rsos.181156","volume":"5","author":"Y Lin","year":"2018","unstructured":"Lin Y, Ren Y, Zhang Y, Zhou J, Zhou F, Zhao Q, et al. Protective role of nano-selenium-enriched Bifidobacterium longum in delaying the onset of streptozotocin-induced diabetes. R Soc Open Sci. 2018;5:181156.","journal-title":"R Soc Open Sci"},{"key":"4431_CR174","doi-asserted-by":"publisher","first-page":"9547","DOI":"10.1039\/C8NR02538J","volume":"10","author":"J Chu","year":"2018","unstructured":"Chu J, Shi P, Yan W, Fu J, Yang Z, He C, et al. PEGylated graphene oxide-mediated quercetin-modified collagen hybrid scaffold for enhancement of MSCs differentiation potential and diabetic wound healing. Nanoscale. 2018;10:9547\u201360.","journal-title":"Nanoscale"},{"key":"4431_CR175","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1039\/D2BM01443B","volume":"11","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Kong L, Wang Q, Wang H, Yang Y, Fu J, et al. A biotin-stabilized HKUST-1\/ADM scaffold for facilitating MSC endothelial differentiation and vascularization in diabetic wound healing. Biomater Sci. 2023;11:854\u201372.","journal-title":"Biomater Sci"},{"key":"4431_CR176","doi-asserted-by":"publisher","first-page":"117955141988360","DOI":"10.1177\/1179551419883608","volume":"12","author":"JF Rehfeld","year":"2019","unstructured":"Rehfeld JF. Premises for cholecystokinin and gastrin peptides in diabetes therapy. Clin Med Insights Endocrinol Diabetes. 2019;12:1179551419883608.","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"4431_CR177","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/08916934.2021.2012165","volume":"55","author":"M-C Gaudreau","year":"2022","unstructured":"Gaudreau M-C, Gudi RR, Li G, Johnson BM, Vasu C. Gastrin producing syngeneic mesenchymal stem cells protect non-obese diabetic mice from type 1 diabetes. Autoimmunity. 2022;55:95\u2013108.","journal-title":"Autoimmunity"},{"key":"4431_CR178","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1007\/s12015-017-9760-2","volume":"13","author":"GS Oggu","year":"2017","unstructured":"Oggu GS, Sasikumar S, Reddy N, Ella KKR, Rao CM, Bokara KK. Gene delivery approaches for mesenchymal stem cell therapy: strategies to increase efficiency and specificity. Stem Cell Rev Rep. 2017;13:725\u201340.","journal-title":"Stem Cell Rev Rep"},{"key":"4431_CR179","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.ecl.2013.09.004","volume":"43","author":"S Kurra","year":"2014","unstructured":"Kurra S, Fink DA, Siris ES. Osteoporosis-associated fracture and diabetes. Endocrinol Metab Clin. 2014;43:233\u201343.","journal-title":"Endocrinol Metab Clin"},{"key":"4431_CR180","doi-asserted-by":"publisher","first-page":"e2425106","DOI":"10.1001\/jamanetworkopen.2024.25106","volume":"7","author":"M Zoulakis","year":"2024","unstructured":"Zoulakis M, Johansson L, Litsne H, Axelsson K, Lorentzon M. Type 2 diabetes and fracture risk in older women. JAMA Netw Open. 2024;7:e2425106.","journal-title":"JAMA Netw Open"},{"key":"4431_CR181","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/MED.0b013e328331c7eb","volume":"16","author":"NB Khazai","year":"2009","unstructured":"Khazai NB, Beck GR, Umpierrez GE. Diabetes and fractures: an overshadowed association. Curr Opin Endocrinol Diabetes Obes. 2009;16:435\u201345.","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"4431_CR182","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00125-014-3470-y","volume":"58","author":"KI Ko","year":"2015","unstructured":"Ko KI, Coimbra LS, Tian C, Alblowi J, Kayal RA, Einhorn TA, et al. Diabetes reduces mesenchymal stem cells in fracture healing through a TNF\u03b1-mediated mechanism. Diabetologia. 2015;58:633\u201342.","journal-title":"Diabetologia"},{"key":"4431_CR183","doi-asserted-by":"publisher","first-page":"60","DOI":"10.5483\/BMBRep.2023-0113","volume":"57","author":"AR Han","year":"2024","unstructured":"Han AR, Shin HR, Kwon J, Lee SB, Lee SE, Kim E-Y, et al. Highly efficient genome editing via CRISPR-Cas9 ribonucleoprotein (RNP) delivery in mesenchymal stem cells. BMB Rep. 2024;57:60\u20135.","journal-title":"BMB Rep"},{"key":"4431_CR184","first-page":"98","volume":"133","author":"E-L Wu","year":"2023","unstructured":"Wu E-L, Cheng M, Zhang X-J, Wu T-G, Zhang L. The role of non-coding RNAs in diabetes-induced osteoporosis. Differ Res Biol Divers. 2023;133:98\u2013108.","journal-title":"Differ Res Biol Divers"},{"key":"4431_CR185","doi-asserted-by":"publisher","first-page":"9281520","DOI":"10.1155\/2019\/9281520","volume":"2019","author":"X Liu","year":"2019","unstructured":"Liu X, Rui T, Zhang S, Ding Z. Heterogeneity of MSC: origin, molecular identities, and functionality. Stem Cells Int. 2019;2019:9281520.","journal-title":"Stem Cells Int"},{"key":"4431_CR186","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-3-030-11096-3_6","volume":"1123","author":"Y Hayashi","year":"2019","unstructured":"Hayashi Y, Ohnuma K, Furue MK. Pluripotent stem cell heterogeneity. Adv Exp Med Biol. 2019;1123:71\u201394.","journal-title":"Adv Exp Med Biol"},{"key":"4431_CR187","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00018-020-03600-0","volume":"78","author":"LA Costa","year":"2021","unstructured":"Costa LA, Eiro N, Fraile M, Gonzalez LO, Sa\u00e1 J, Garcia-Portabella P, et al. Functional heterogeneity of mesenchymal stem cells from natural niches to culture conditions: implications for further clinical uses. Cell Mol Life Sci CMLS. 2021;78:447\u201367.","journal-title":"Cell Mol Life Sci CMLS"},{"key":"4431_CR188","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/978-3-030-11096-3_10","volume":"1123","author":"W Wang","year":"2019","unstructured":"Wang W, Han ZC. Heterogeneity of human mesenchymal stromal\/stem cells. Adv Exp Med Biol. 2019;1123:165\u201377.","journal-title":"Adv Exp Med Biol"},{"key":"4431_CR189","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13287-019-1334-6","volume":"10","author":"D Hladik","year":"2019","unstructured":"Hladik D, H\u00f6fig I, Oestreicher U, Beckers J, Matjanovski M, Bao X, et al. Long-term culture of mesenchymal stem cells impairs ATM-dependent recognition of DNA breaks and increases genetic instability. Stem Cell Res Ther. 2019;10:218.","journal-title":"Stem Cell Res Ther"},{"key":"4431_CR190","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3390\/cells8080886","volume":"8","author":"Y Han","year":"2019","unstructured":"Han Y, Li X, Zhang Y, Han Y, Chang F, Ding J. Mesenchymal stem cells for regenerative medicine. Cells. 2019;8:886.","journal-title":"Cells"},{"key":"4431_CR191","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/5584_2019_476","volume":"1247","author":"S Aydin","year":"2020","unstructured":"Aydin S, Sa\u011fra\u00e7 D, \u015eahin F. Differentiation potential of mesenchymal stem cells into pancreatic \u03b2-cells. Adv Exp Med Biol. 2020;1247:135\u201356.","journal-title":"Adv Exp Med Biol"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04431-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-025-04431-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-025-04431-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T09:03:12Z","timestamp":1750150992000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-025-04431-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":191,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4431"],"URL":"https:\/\/doi.org\/10.1186\/s13287-025-04431-1","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"21 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"308"}}